Test Code CRDPU Creatine Disorders Panel, Random, Urine
Performing Laboratory
Mayo Clinic Laboratories in RochesterReporting Name
Creatine Disorders Panel, USpecimen Type
UrineNecessary Information
Patient's age and sex are required.
Specimen Required
Supplies: Urine Tubes, 10 mL (T068)
Container/Tube: Plastic, 10 mL urine tube
Specimen Volume: 1 mL
Collection Instructions:
1. Collect a random urine specimen.
2. Immediately freeze urine specimen.
3. If possible, do not send other tests ordered on same vial of urine. In doing so, the other tests may have increased turnaround time due to the strict frozen criteria of this assay.
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Frozen | 29 days |
Specimen Minimum Volume
0.5 mL
Special Instructions
Day(s) Performed
Tuesday
Specimen Retention Time
1 monthReport Available
3 to 9 daysReference Values
Males
Age |
Creatinine (nmol/mL) |
Guanidinoacetate (nmol/mL) |
Creatine (nmol/mL) |
Creatine/ creatinine |
≤31 days |
430-5,240 |
9-210 |
12-2,930 |
0.02-0.93 |
32 days-23 months |
313-9,040 |
16-860 |
18-10,490 |
0.02-2.49 |
2-4 years |
1,140-12,820 |
90-1,260 |
200-9,210 |
0.04-1.75 |
5-18 years |
1,190-25,270 |
40-1,190 |
60-9,530 |
0.01-0.96 |
>18 years (male) |
3,854-23,340 |
30-710 |
7-470 |
0.00-0.04 |
Females
Age |
Creatinine (nmol/mL) |
Guanidinoacetate (nmol/mL) |
Creatine (nmol/mL) |
Creatine/ creatinine |
≤31 days |
430-5,240 |
9-210 |
12-2,930 |
0.02-0.93 |
32 days-23 months |
313-9,040 |
16-860 |
18-10,490 |
0.02-2.49 |
2-4 years |
1,140-12,820 |
90-1,260 |
200-9,210 |
0.04-1.75 |
5-18 years |
1,190-25,270 |
40-1,190 |
60-9,530 |
0.01-0.96 |
>18 years |
1,540-18,050 |
30-760 |
5-2810 |
0.00-0.46 |
Additional Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
CRBO | Creatine, (Bill Only), U | No | Yes |
CRNBO | Creatinine, (Bill Only), U | No | Yes |
GAABO | Guanidinoacetate, (Bill Only), U | No | Yes |
Useful For
Evaluating patients with a clinical suspicion of arginine:glycine amidinotransferase deficiency, guanidinoacetate methyltransferase deficiency, and creatine transporter (SLC6A8) defect
Testing Algorithm
This is a single test that carries the results for the panel. When the test has been resulted, the following procedures are billed:
-CRBO / Creatine, Urine (Bill Only)
-CRNBO / Creatinine, Urine (Bill Only)
-GAABO / Guanidinoacetate, Urine (Bill Only)
For more information see:
-Newborn Screen Follow-up for Guanidinoacetate Methyltransferase Deficiency (GAMT)
-Epilepsy: Unexplained Refractory and/or Familial Testing Algorithm
CPT Code Information
82540
82570
82542
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CRDPU | Creatine Disorders Panel, U | 79290-3 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
23383 | Creatine | 15046-6 |
23384 | Creatinine | 14683-7 |
23385 | Guanidinoacetate | 97148-1 |
23268 | Creatine/Creatinine Ratio | 34275-8 |
23270 | Creatine Disorders Panel Interp | 79292-9 |
23272 | Reviewed By | 18771-6 |
Disease States
- CrT1 defect
- Creatine transporter (SLC6A8) deficiency
Forms
If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.
Genetics Test Information
Depletion of cerebral creatine occurs in all 3 types of creatine deficiency syndromes (CDS): arginine:glycine amidinotransferase deficiency, guanidinoacetate methyltransferase deficiency, and creatine transporter (SLC6A8) deficiency.
Measurement of guanidinoacetate, creatine (Cr), and creatinine (Crn) in urine, along with the Cr:Crn ratio, aids in distinguishing the types of creatine deficiency syndromes.
Treatment with oral creatine supplementation is effective in some types of CDS.
Creatine supplementation may cause increased creatine values.